SBIO Continues Rally on Breakthrough Drug Data

The ALPS Medical Breakthroughs ETF (SBIO) rallied 11.53% last week on positive trial data and merger and acquisition news that revived the biotech sector. The small- and mid-cap biotech companies among SBIO’s holdings outperformed large-cap biotech indexes by nearly 200 bps last week on positive...